Cloned (Comment) | Organism |
---|---|
recombinantly expressed in Pichia pastoris | Fasciola hepatica |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
benzyloxycarbonyl-Phe-Ala-diazomethyl ketone | FheCL2 | Fasciola hepatica | |
cathepsin K inhibitor II | FheCL2 | Fasciola hepatica |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0014 | - |
benzyloxycarbonyl-L-Leu-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
0.0153 | - |
tosyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
0.0337 | - |
tert-butoxycarbonyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
0.04 | - |
benzyloxycarbonyl-L-Phe-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
0.084 | - |
benzyloxycarbonyl-L-Pro-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Fasciola hepatica | Q24940 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
proteolytic modification | FhCL2 is expressed as 37000 Da zymogen that autocatalytically processes at pH 4.5 to produce a 24500 Da mature enzyme | Fasciola hepatica |
Purification (Comment) | Organism |
---|---|
recombinant zymogen of cathepsin L2 | Fasciola hepatica |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyloxycarbonyl-L-Leu-L-Arg-4-methylcoumarinyl-7-amide + H2O | FhCL2 | Fasciola hepatica | benzyloxycarbonyl-L-Leu-L-Arg + 7-amino-4-methylcoumarin | - |
? | |
benzyloxycarbonyl-L-Phe-L-Arg-4-methylcoumarinyl-7-amide + H2O | FhCL2 | Fasciola hepatica | benzyloxycarbonyl-L-Phe-L-Arg + 7-amino-4-methylcoumarin | - |
? | |
benzyloxycarbonyl-L-Pro-L-Arg-4-methylcoumarinyl-7-amide + H2O | FhCL2 | Fasciola hepatica | benzyloxycarbonyl-L-Pro-L-Arg + 7-amino-4-methylcoumarin | - |
? | |
Collagen + H2O | whereas FheCL1 produces clear degradation fragments, FheCL2 degrades the collagen completely, particularly at pH 4.0, indicating that only the latter cleaves efficiently within the helical structures | Fasciola hepatica | ? | - |
? | |
additional information | FheCL1 and FheCL2 exhibit similar preferences for amino acids at P1. Both enzymes have a clear preference for Arg at P1 position, but other residues accommodate in this position include Lys, Glu, Thr, and Met. These are all cleaved at similar relative rates to that observed for human cathepsin L and cathepsin K. FheCL1 and FheCL2 are similar to cathepsin K with regard to their preference for a P2 position Leu over Phe (human cathepsin L has a preference for P2 position Phe over Leu). Both enzymes can accommodate Pro in the P2 position, but this is more readily accepted by FheCL2 compared with FheCL1. Neither enzyme, however, cleaves substrates with this residue in the P2 position as readily as human cathepsin K | Fasciola hepatica | ? | - |
? | |
tert-butoxycarbonyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide + H2O | FhCL2 | Fasciola hepatica | tert-butoxycarbonyl-Gly-Pro-Arg + 7-amino-4-methylcoumarin | - |
? | |
tosyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide + H2O | FhCL2 | Fasciola hepatica | tosyl-Gly-Pro-Arg + 7-amino-4-methylcoumarin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
FhCL2 | - |
Fasciola hepatica |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
1.17 | - |
tosyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
1.62 | - |
benzyloxycarbonyl-L-Leu-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
1.7 | - |
benzyloxycarbonyl-L-Phe-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
2.48 | - |
tert-butoxycarbonyl-Gly-Pro-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica | |
2.64 | - |
benzyloxycarbonyl-L-Pro-L-Arg-4-methylcoumarinyl-7-amide | FheCL2 | Fasciola hepatica |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000023 | - |
cathepsin K inhibitor II | FheCL2 | Fasciola hepatica | |
0.00167 | - |
benzyloxycarbonyl-Phe-Ala-diazomethyl ketone | FheCL2 | Fasciola hepatica |